Your browser is no longer supported. Please, upgrade your browser.
Settings
INVA Innoviva, Inc. daily Stock Chart
INVA [NASD]
Innoviva, Inc.
Index- P/E3.94 EPS (ttm)3.49 Insider Own0.10% Shs Outstand102.73M Perf Week-2.97%
Market Cap1.41B Forward P/E7.47 EPS next Y1.84 Insider Trans20.24% Shs Float66.91M Perf Month-7.72%
Income395.10M PEG0.20 EPS next Q0.45 Inst Own80.30% Short Float27.78% Perf Quarter-16.63%
Sales261.00M P/S5.41 EPS this Y211.30% Inst Trans6.50% Short Ratio15.20 Perf Half Y-9.43%
Book/sh1.52 P/B9.04 EPS next Y-2.39% ROA109.60% Target Price15.00 Perf Year-15.34%
Cash/sh1.12 P/C12.28 EPS next 5Y19.34% ROE-480.80% 52W Range13.26 - 20.54 Perf YTD-21.26%
Dividend- P/FCF6.32 EPS past 5Y68.70% ROI81.00% 52W High-33.11% Beta1.80
Dividend %- Quick Ratio34.90 Sales past 5Y124.90% Gross Margin- 52W Low3.62% ATR0.46
Employees6 Current Ratio34.90 Sales Q/Q15.00% Oper. Margin91.30% RSI (14)26.29 Volatility2.57% 3.26%
OptionableYes Debt/Eq2.49 EPS Q/Q374.90% Profit Margin- Rel Volume0.68 Prev Close13.95
ShortableYes LT Debt/Eq2.49 EarningsFeb 07 AMC Payout0.00% Avg Volume1.22M Price13.74
Recom- SMA20-6.29% SMA50-15.73% SMA200-11.55% Volume834,377 Change-1.51%
Nov-20-17Initiated Deutsche Bank Hold $13
Mar-08-19 08:00PM  A Dozen 13D Deals Barrons.com
02:21PM  How Many Insiders Bought Innoviva, Inc. (NASDAQ:INVA) Shares? Simply Wall St.
Feb-19-19 05:48PM  Innoviva Inc (INVA) Files 10-K for the Fiscal Year Ended on December 31, 2018 GuruFocus.com
Feb-15-19 04:27PM  Innoviva, Inc. -- Moody's announces completion of a periodic review of ratings of Innoviva, Inc. Moody's
Feb-07-19 02:39PM  Buy the Dip on This Pharma Stock Schaeffer's Investment Research
Feb-06-19 05:57PM  Innoviva: 4Q Earnings Snapshot Associated Press -6.00%
04:05PM  Innoviva Reports Fourth Quarter 2018 Financial Results Business Wire
08:15AM  Report: Developing Opportunities within Xcel Energy, Empire State Realty Trust, Innoviva, Tyler Technologies, Tower International, and Nathan's Famous Future Expectations, Projections Moving into 2019 GlobeNewswire
Jan-30-19 04:09PM  Mylan Pops After FDA Approves Its Knockoff Of Glaxo's Asthma Inhaler Investor's Business Daily -9.17%
Jan-22-19 01:37PM  Why Innoviva, Inc. (NASDAQ:INVA) Is An Attractive Investment To Consider Simply Wall St.
Jan-11-19 03:30PM  Dow Jones Gives Back Little Of Its 1,100-Point Rebound; 3 Signs Stock Market Bears Are Retreating Investor's Business Daily
Jan-01-19 09:21AM  3 Under-the-Radar Value Stocks to Buy in 2019 Motley Fool
Dec-20-18 09:30AM  Is Innoviva (INVA) Stock Outpacing Its Medical Peers This Year? Zacks
Dec-17-18 03:10PM  IBD 50 Stocks To Watch: Innoviva Resilient As Broad Market Struggles Investor's Business Daily
Dec-14-18 12:39AM  Hedge Funds Arent Crazy About Innoviva, Inc. (INVA) Anymore Insider Monkey
Dec-06-18 09:37AM  3 Reasons Momentum Stock Investors Will Love Innoviva (INVA) Zacks
Nov-23-18 12:03PM  Stocks Trim Losses As Consumer Stocks Rise At Start Of Holiday Shopping Season Investor's Business Daily +5.39%
Nov-20-18 04:25PM  IBD Stock Of The Day Breezes Toward Breakout On New Inhaler Uses Investor's Business Daily
Nov-13-18 09:22AM  Glaxo/Innoviva's Trelegy Ellipta Gets Line Extension in Europe Zacks
Nov-09-18 07:56AM  Moving Average Crossover Alert: Innoviva (INVA) Zacks
07:01AM  Once-daily Trelegy Ellipta gains expanded COPD indication in Europe Business Wire
Nov-06-18 07:30AM  Research Report Identifies Oil States International, Brightcove, Electronics for Imaging, Cirrus Logic, Innoviva, and Marinus Pharmaceuticals with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Nov-05-18 03:01PM  IBD 50 Stocks To Watch: This Stock Rallied Despite A Miss On Earnings And Revenue Investor's Business Daily
Oct-31-18 04:31PM  Innoviva: 3Q Earnings Snapshot Associated Press -6.31%
04:05PM  Innoviva Reports Third Quarter 2018 Financial Results Business Wire
Sep-21-18 07:30AM  Trelegy Ellipta Receives Positive CHMP Opinion Supporting Expanded COPD Indication in Europe Business Wire
Sep-05-18 02:57PM  Should You Be Worried When Innoviva Incs (NASDAQ:INVA) Insiders Sell? Simply Wall St.
Aug-28-18 07:35AM  Report: Exploring Fundamental Drivers Behind Allscripts Healthcare Solutions, Dean Foods, Alder BioPharmaceuticals, Innoviva, Chegg, and TEGNA New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Jul-26-18 04:05PM  Innoviva Reports Second Quarter 2018 Financial Results Business Wire
Jul-17-18 12:33PM  GlaxoSmithKline Is More Than Just a 5% Dividend Income Play InvestorPlace
Jul-13-18 07:30AM  Free Technical Research on Insmed and Three More Biotech Equities ACCESSWIRE
Jun-26-18 12:02PM  Innoviva And Other Great Growth Stocks Simply Wall St.
07:55AM  Recent Analysis Shows Church & Dwight Co., Innoviva, PTC Therapeutics, KBR, Murphy Oil, and F.N.B. Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Jun-15-18 10:21AM  3 Top Healthcare Stocks to Buy in June Motley Fool
Jun-11-18 07:38AM  The Cheapest Drug Stocks to Buy Right Now Motley Fool
May-30-18 10:33AM  Glaxo/Innoviva File for Approval of Trelegy Ellipta in Japan Zacks
May-29-18 02:00AM  GSK Submits Regulatory Application in Japan for Once-Daily Single Inhaler Triple Therapy FF/UMEC/VI for Patients with COPD Business Wire
May-22-18 04:05PM  Innoviva Names Geoffrey Hulme as Interim Principal Executive Officer Business Wire
May-14-18 10:02AM  Top Cheap Stocks To Buy Simply Wall St.
May-08-18 08:25AM  Research Report Identifies ILG, Innoviva, iRobot, KBR, KapStone Paper and Packaging, and Lumentum with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
May-01-18 07:50AM  Blog Exposure - INSYS Commences Phase-2 Clinical Trial of Cannabidiol Oral Solution for Treatment of Prader-Willi Syndrome ACCESSWIRE
Apr-26-18 08:23AM  Innoviva: 1Q Earnings Snapshot Associated Press
08:00AM  Innoviva Reports First Quarter 2018 Financial Results Business Wire
Apr-24-18 12:55PM  Once-Daily Trelegy Ellipta Gains Expanded Indication in the US for the Treatment of Patients With COPD Business Wire
Apr-18-18 05:00PM  Landmark IMPACT Study Published in NEJM Shows Significant Benefits of Trelegy Ellipta for Patients with COPD Business Wire
Apr-03-18 09:42AM  Biotech Stock Tests Buy Zone, Gets New Approval For Asthma Drug Relvar Ellipta Investor's Business Daily
Mar-29-18 10:02AM  Flavor Of The Month: Innoviva And More Simply Wall St.
Mar-28-18 12:02PM  March Growth Stock Opportunities Simply Wall St.
Mar-09-18 06:02PM  Have Investors Priced In Innoviva Incs (NASDAQ:INVA) Growth? Simply Wall St.
Mar-08-18 03:00AM  GSK Announces Positive EU Approval for Labelling Update to Relvar Ellipta in Patients with Asthma Business Wire
Mar-06-18 08:15AM  Report: Exploring Fundamental Drivers Behind Okta, Conduent, Innoviva, PRA Health Sciences, DDR, and Tenet Healthcare New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Feb-21-18 08:27AM  New Strong Sell Stocks for February 21st Zacks
Feb-19-18 02:40AM  How Do Analysts See Innoviva Inc (NASDAQ:INVA) Performing In The Years Ahead? Simply Wall St.
Feb-14-18 04:00AM  GSK Submits Landmark IMPACT Data to European Medicines Agency to Support Expanded Label for Trelegy Ellipta Business Wire
Feb-13-18 04:05PM  Why Innoviva Inc. Stock Jumped Tuesday Motley Fool +9.97%
11:38AM  Sarissa Capital Reconstitutes Innoviva Board Of Directors PR Newswire
Feb-12-18 10:01PM  Drug company Innoviva settles with activist hedge fund Sarissa -sources Reuters
Feb-09-18 02:09PM  Edited Transcript of INVA earnings conference call or presentation 8-Feb-18 10:00pm GMT Thomson Reuters StreetEvents +11.81%
Feb-08-18 07:07PM  Innoviva beats Street 4Q forecasts Associated Press
04:05PM  Innoviva Reports Record Fourth Quarter and Full Year 2017 Financial Results Business Wire
01:40PM  Innoviva, Inc. to Host Earnings Call ACCESSWIRE
Feb-02-18 04:05PM  Innoviva to Report Fourth Quarter Financial Results on February 8 at 5:00 p.m. EDT Business Wire
Jan-26-18 04:00AM  GSK Announces CHMP Positive Opinion for Labelling Update to Relvar Ellipta in Patients with Asthma Business Wire
Jan-09-18 08:02AM  See what the IHS Markit Score report has to say about Innoviva Inc. Markit
Jan-02-18 08:05AM  See what the IHS Markit Score report has to say about Innoviva Inc. Markit
Dec-30-17 05:45PM  Does Innoviva Incs (NASDAQ:INVA) PE Ratio Warrant A Buy? Simply Wall St.
Dec-27-17 03:00AM  Innoviva Sees RS Rating Rise To 74 Investor's Business Daily
Dec-22-17 03:00AM  Innoviva Earns Relative Strength Rating Upgrade Investor's Business Daily
Dec-21-17 11:32AM  ETFs with exposure to Innoviva, Inc. : December 21, 2017 Capital Cube
Dec-19-17 04:05PM  Innoviva and Sarissa Implement Court Order Business Wire
Dec-12-17 07:23AM  Innoviva, Inc. breached its 50 day moving average in a Bullish Manner : INVA-US : December 12, 2017 Capital Cube
Dec-08-17 08:05AM  See what the IHS Markit Score report has to say about Innoviva Inc. Markit
Dec-01-17 10:39AM  ETFs with exposure to Innoviva, Inc. : December 1, 2017 Capital Cube
Nov-30-17 09:44AM  Innoviva, Inc. :INVA-US: Earnings Analysis: Q3, 2017 By the Numbers : November 30, 2017 Capital Cube
Nov-28-17 08:04AM  See what the IHS Markit Score report has to say about Innoviva Inc. Markit
Nov-23-17 09:12AM  Glaxo (GSK) Files for U.S. Label Expansion of COPD Inhaler Zacks
02:00AM  GSK Submits Landmark IMPACT Data to US Regulatory Authority to Support Expanded Label for Trelegy Ellipta Business Wire
Nov-22-17 08:05AM  See what the IHS Markit Score report has to say about Innoviva Inc. Markit
07:31AM  Innoviva, Inc. breached its 50 day moving average in a Bullish Manner : INVA-US : November 22, 2017 Capital Cube
Nov-20-17 07:50AM  Corporate News Blog - GlaxoSmithKline and Innovivas Trelegy Ellipta Gets Marketing Authorization for the Treatment of COPD in Europe ACCESSWIRE
Nov-17-17 04:41PM  Theravance Shares Rise on Approval of Glaxo's COPD Therapy Zacks
03:16PM  Glaxo's Triple Therapy COPD Inhaler Gets Marketing Nod in EU Zacks
Nov-16-17 02:00AM  Trelegy Ellipta Once-Daily Single Inhaler Triple Therapy Gains Marketing Authorisation in Europe for the Treatment of COPD Business Wire
Nov-10-17 08:14AM  See what the IHS Markit Score report has to say about Innoviva Inc. Markit
Nov-09-17 08:20AM  Factors of Influence in 2018, Key Indicators and Opportunity within Tegna, Inpixon, Honeywell International, Nektar, PDL Biopharma, and Innoviva New Research Emphasizes Economic Growth GlobeNewswire
Nov-08-17 03:00PM  Largest Shareholders of GlaxcoSmithKline Investopedia
Nov-01-17 04:05PM  Innoviva to Participate at the Credit Suisse and Stifel Annual Healthcare Conferences in November Business Wire
07:00AM  GSK Study Demonstrates Superiority of Anoro Ellipta to Stiolto Respimat in Improving Lung Function in Chronic Obstructive Pulmonary Disease Business Wire
Oct-27-17 11:36AM  Innoviva, Inc. Value Analysis (NASDAQ:INVA) : October 27, 2017 Capital Cube
Oct-26-17 08:20AM  Innoviva, Inc. breached its 50 day moving average in a Bearish Manner : INVA-US : October 26, 2017 Capital Cube
04:34AM  Edited Transcript of INVA earnings conference call or presentation 25-Oct-17 9:00pm GMT Thomson Reuters StreetEvents
Oct-25-17 05:51PM  Innoviva misses 3Q profit forecasts Associated Press -15.55%
05:07PM  Why Did Innoviva, Inc. Stock Fall Nearly 16% Wednesday? Motley Fool
04:05PM  Innoviva Reports Third Quarter 2017 Financial Results and Provides Business Updates Business Wire
08:10AM  Innoviva, Inc. to Host Earnings Call ACCESSWIRE
Oct-20-17 10:16AM  ETFs with exposure to Innoviva, Inc. : October 20, 2017 Capital Cube
Oct-18-17 04:05PM  Innoviva to Report Third Quarter Financial Results on October 25 at 5:00 p.m. EDT Business Wire
Oct-09-17 11:40AM  ETFs with exposure to Innoviva, Inc. : October 9, 2017 Capital Cube
08:02AM  See what the IHS Markit Score report has to say about Innoviva Inc. Markit
Oct-06-17 03:00AM  Stocks With Rising Relative Price Strength: Innoviva Investor's Business Daily
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals. The company has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a long-acting beta2 agonist (LABA), vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate (FF); ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA), umeclidinium bromide (UMEC), with a LABA, and VI; and TRELEGY ELLIPTA, a once-daily combination medicine consisting of an ICS, LAMA and LABA. The company was formerly known as Theravance, Inc. and changed its name to Innoviva, Inc. in January 2016. Innoviva, Inc. was incorporated in 1996 and is headquartered in Brisbane, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bickerstaff GeorgeDirectorFeb 21Buy14.9010,000148,95838,762Feb 22 05:27 PM
HULME GEOFFREYInterim PEOFeb 15Buy14.807,000103,6007,000Feb 20 04:02 PM
ABERCROMBIE GEORGE BSr. VP & Chief Comm. OfficerAug 21Sale14.118,000112,840285,479Aug 22 06:46 PM
Witek Theodore J. Jr.Sr. VP & Chief Scientific Off.Aug 21Sale14.128,504120,080247,767Aug 22 06:43 PM
dEsparbes EricSVP and CFOMay 21Sale14.405,80883,623373,081May 22 07:53 PM
ABERCROMBIE GEORGE BSr. VP & Chief Comm. OfficerMay 21Sale14.408,000115,202299,159May 22 07:52 PM